First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - DOBSON PHARMACEUTICAL ASSOCIATES LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: DOBSON PHARMACEUTICAL ASSOCIATES LTD, 3rd Floor The Pinnacle, 73 King Street, Manchester, M2 4NG. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 30 September 2015. The company was incorporated on 18 March 2010.

The accounts next due date is 30 June 2017. There are no mortgages.

The above was based on public record information as at 14 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 07194828
Date Incorporated: 18 March 2010
Date Latest Accounts: 30 September 2015
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 07194828
Annual Return: 21 February 2015
Registered Office: 3rd Floor The Pinnacle, 73 King Street, Manchester, M2 4NG
SIC Code and Operations: 74909
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DOBSON PHARMACEUTICAL ASSOCIATES LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 24 April 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
15400489 DOBSON PLUMBING & HEATING LTD Active
09679093 DOBSON PROCESS LTD Active - Proposal to Strike off
08022878 DOBSON PROJECTS LIMITED Active
SC100609 DOBSON PROPERTIES LIMITED Liquidation
14696062 DOBSON PROPERTIES LTD Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd